Mir Lim1, Magdalena Espinoza2, Yi-Hsiang Huang3

  • 1Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.

JAMA network open
|February 25, 2025
PubMed
概括

肝细胞癌患者在免疫疗法获得完整反应后,表现为持久的生存和罕见的复发. 像PD-L1表达和瘤DNA水平这样的生物标志物可以预测这些结果.